Main menu


Daily Mail: The AstraZeneca vaccine protects with 97% of the Indian strain of Coronavirus

Matt Hancock, Britain's health minister, said today, Monday, that initial indications are that vaccines protect elderly people from the worrisome variable that was first discovered in India, and that most people who were hospitalized after contracting the Coronavirus were not vaccinated, according to Reported by Reuters.

A recent study confirmed that Corona virus vaccines are 97% effective against infection from the Indian strain of Coronavirus.

Matt Hancock said there were 2,323 confirmed cases of the B.1.617.2 variant, and in the northwestern town of Bolton, the majority of the 19 people hospitalized had not been vaccinated even though they were eligible.

"This shows that the new variant does not tend to penetrate into older vaccinated groups, and reiterates the importance of getting the vaccine," Hancock told Parliament.

According to the British newspaper "Daily Mail", scientists claim that vaccines prevent 97% of Corona infections from the Indian strain.

Those who were given a single dose of the AstraZeneca vaccine had 97.38% protection from infection, said the lead researcher who conducted the study on healthcare workers in India.

The risk of them being hospitalized with the strain was only 0.06%, according to research at Indraprastha Apollo Hospital in New Delhi.

Public Health England estimates that vaccines can prevent around 70% of transmission against the Kent variant.

Little is known about how well vaccines work in the Indian variant because the UK has only recorded 1,313 cases.

Health Secretary Matt Hancock revealed that of the 18 people who were hospitalized with the surrogate at Bolton Hotspot, only one person was fully vaccinated, although most of them were eligible, adding that the fully vaccinated patient was "extremely weak". It was thus susceptible to infection, and 5 other patients had only received the first dose.

The newspaper added, that data from laboratory studies on the effectiveness of vaccines on the new strain was "somewhat promising."

Sir John Bell of the University of Oxford who is conducting the research said the new variant appears to slightly reduce the ability to neutralize the virus.

The study at Indraprastha Apollo Hospital in New Delhi did not record any deaths or admissions to the intensive care unit among patients who were vaccinated with the AstraZeneca vaccine, as the researchers confirmed that the study shed light on the power of vaccination.

Dr. Anupam Sibal, the group's medical director, told The Telegraph: "Our study showed that 97.38% of those vaccinated were protected from Corona infection, and that the hospitalization rate was only 0.06%."